Loading...
Dear Readers,
As we have done for several years, we present the top stories of 2010 from Journal Watch Gastroenterology. This compilation includes both my choices of the most relevant stories and the stories that you read most often (based on the number of online views of each article). Much as we did last year, you and I created very different lists, but we often focused on different aspects of the same topics.
First, the colon still rules. You picked stories on adenoma detection rates, aspirin for prophylaxis of colonic neoplasia, comparisons of screening techniques related to colon cancer, stool enemas for Clostridium difficile infection, and antibiotics for ulcerative colitis. In contrast, I chose preparation issues for afternoon colonoscopies, nongastroenterologists performing colonoscopies and missing cancers, and the “skeleton in the closet” — right-sided cancers following colonoscopy. You were not as interested in the liver this year (only triple therapy for hepatitis C made your top 10), whereas I selected stories about combination medical and endoscopic therapy for preventing variceal hemorrhage in cirrhosis patients, transjugular intrahepatic portosystemic shunts for variceal bleeding, telaprevir for hepatitis C infection, and rifaximin for hepatic encephalopathy. You also still closely followed the clopidogrel story that I (apparently erroneously) thought was no longer of primary interest to readers.
Regardless of our different choices, these stories are great reads, and I encourage you to check them out if you haven't already. As with all our coverage, our goals are to help you gain a broader perspective about topics that are relevant to your colleagues and to stay up-to-speed on research findings that you can use in your daily clinical and professional lives.
Let us know what you think by sending us an e-mail at jwgastro@mms.org.
Here's to another great year in 2011, with stories focused on what we need to know to improve digestive health in our patients.